Current Clinical Trials

IN STARTUP: TORNIER PERFORM™ Reversed MONOPOST STUDY (Monarch STUDY)
  1. David Savin, MD
    David Savin, MD
  2. for people 18 Years and up (full criteria)
  3. Rancho Mirage, CA
  4. David Savin, MD
  5. Accepting new patients

Description

Summary

Multi-center, Prospective Follow-up, Non-significant risk, Post-Market Clinical Follow-Up (PMCF) study to Evaluate the Safety and Effectiveness of the Tornier Perform™ Reversed MonoPost System

Official Title

IN STARTUP: TORNIER PERFORM™ Reversed MONOPOST STUDY (Monarch STUDY)

Detailed Description

It is anticipated that a total of 150 subjects will be enrolled at up to ten sites over a one year enrollment period. The study has been designed to follow the surgeon’s standard of care for subjects treated with shoulder arthroplasty with the device including imaging (x-rays and or CT scans).The primary endpoint of this study is to demonstrate pain relief and improved subjects’ shoulder functionality by achieving a mean target of 25-points Total ASES Score improvement, for each type of glenoid ... more
less

It is anticipated that a total of 150 subjects will be enrolled at up to ten sites over a one year enrollment period. The study has been designed to follow the surgeon’s standard of care for subjects treated with shoulder arthroplasty with the device including imaging (x-rays and or CT scans).The primary endpoint of this study is to demonstrate pain relief and improved subjects’ shoulder functionality by achieving a mean target of 25-points Total ASES Score improvement, for each type of glenoid (two sub cohorts: Standard with/without BIO-RSA and Augmented baseplate) at 2 years follow-up compared to baseline. Secondary objectives are to collect postoperative data on the related clinical complications and functional outcomes of the device to demonstrate the safety and performance of these implants in a real-world setting.

Keywords

Non-inflammatory Degenerative Joint Disease

Eligibility

for people 18 Years and up
Inclusion Criteria:* 18 years or older at the time of the informed consent.* Informed and willing to sign an informed consent form (ICF) approved by Institutional Review Board (IRB) or Ethics Committee (EC).* Willing and able to comply with the requirements of the study protocol* Considered a candidate or having received shoulder arthroplasty with the device, having a functional deltoid muscle and with massive and non-repairable rotator cuff tear with pain disabled by: * Rheumatoid arthritis * N... more
less

Inclusion Criteria:* 18 years or older at the time of the informed consent.* Informed and willing to sign an informed consent form (ICF) approved by Institutional Review Board (IRB) or Ethics Committee (EC).* Willing and able to comply with the requirements of the study protocol* Considered a candidate or having received shoulder arthroplasty with the device, having a functional deltoid muscle and with massive and non-repairable rotator cuff tear with pain disabled by: * Rheumatoid arthritis * Non-inflammatory degenerative joint disease (i.e. osteoarthritis and avascular necrosis) * Correction of functional deformity * Fracture of the Humeral Head * Traumatic arthritis * Revision of the devices if sufficient bone stock remains* Enrollment occurred up to 1 year after date of surgery provided that mandatory data are accessible: including ASES, Constant, and Active ROM.Exclusion Criteria:* Contraindications or hypersensitivity to the use of the Tornier Perform™ Reversed MonoPost System or their components (e.g., metal sensitivity).* Participation in the treatment period of another clinical trial during the clinical investigation.* Any subject that meets the definition of a Vulnerable Subject per ISO 14155 Section 3.44. Examples include any subject "with lack of or loss of autonomy due to immaturity or through mental disability, persons in nursing homes, children, impoverished

Lead Scientists at Eisenhower Health

David Savin, MD
David D.Savin, MD, is a fellowship-trained orthopedic surgeon. He specializes in the diagnosis and treatment of shoulder and elbow disorders, as well as general orthopedics and fracture care. He has significant experience performing arthroscopic management of all shoulder injuries, as well as management of shoulder arthritis with both anatomic and reverse shoulder replacements. His surgical skill set also includes management of shoulder and elbow trauma and common elbow injuries.“I am... more
less

David D.Savin, MD, is a fellowship-trained orthopedic surgeon. He specializes in the diagnosis and treatment of shoulder and elbow disorders, as well as general orthopedics and fracture care. He has significant experience performing arthroscopic management of all shoulder injuries, as well as management of shoulder arthritis with both anatomic and reverse shoulder replacements. His surgical skill set also includes management of shoulder and elbow trauma and common elbow injuries.

“I am grateful to have the ability to help my patients alleviate pain, restore function and return to an active lifestyle.”

Dr. Savin is passionate about helping his patients restore function and stay active after shoulder and elbow injuries. He works with athletes of all ages including high school, college and weekend warriors and his experience includes working with professional teams, such as the Chicago Bulls and Chicago White Sox.

Dr. Savin earned his Bachelor of Science in physiological sciences with Latin honors at the University of California, Los Angeles (UCLA). He continued his medical education at UCLA at the David Geffen School of Medicine. He then moved to Chicago where he completed his surgical internship and orthopedic surgical residency at the University of Illinois. Thereafter, he completed a fellowship in shoulder and elbow surgery at the renowned Midwest Orthopaedics at Rush University Medical Center.

Dr. Savin has conducted extensive research on shoulder and elbow management and surgery on which he has given over 30 national and international presentations and authored dozens of peer-reviewed publications and several book chapters. He is also an active member of the American Academy of Orthopaedic Surgeons.

Dr. Savin, a California native, lives with his wife in Palm Desert. In his free time, he enjoys traveling, hiking, cycling, golf and photography.

Co-Investigators

  1. Karimdad Otarodi, MD

Clinical Study Details

  1. Accepting new patients
  2. Post-Market Clinical Follow-Up Study
  3. November 19, 2026